This inventor holds 1 USPTO granted patent. Top assignee: Teva Gyogyszergyar Reszvenytarsasag. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Arvai Edit Nagyne: Innovator in Pharmaceutical Chemistry
Introduction
Arvai Edit Nagyne is a notable inventor based in Debrecen, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. Her work has led to advancements in the treatment of various health conditions.
Latest Patents
Nagyne holds a patent for "Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same." This invention provides a formulation of pravastatin sodium that is notably free from pravastatin lactone and its C-6 epimer, epi-pravastatin. The patent outlines a novel process for recovering pravastatin sodium from fermentation broth with high purity, which includes several stages such as extraction, obtaining an ammonium salt, purifying the salt, and converting it to pravastatin sodium.
Career Highlights
Nagyne is associated with Teva Gyógyszergyár Részvénytársaság, a prominent pharmaceutical company. Her work at Teva has allowed her to focus on innovative drug formulations and processes that enhance the efficacy and safety of medications.
Collaborations
Throughout her career, Nagyne has collaborated with esteemed colleagues, including Vilmos Keri and Lajos Deak. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Arvai Edit Nagyne's contributions to pharmaceutical chemistry, particularly through her patent on pravastatin sodium, highlight her role as an innovator in the field. Her work continues to impact the development of effective treatments, showcasing the importance of innovation in healthcare.